I agree to the Terms of Use , Privacy Notice and Cookie Notice.

Private equity-owned medical supplies giant Medline is aiming to raise up to $7 billion in an upsized share sale, the Financial Times reported on Tuesday, citing people briefed on the talks.

Starton Holdings plans $40M IPO for cancer drug delivery innovations, but weak IP and limited backing make this a potentially ...

Medline Inc.’s long-delayed initial public offering is on track to raise the most of any listing this year, as investors keen ...

PwC detailed some of the factors that will steer M&A decisions in 2026. Amid policy uncertainty, buyers are demonstrating disciplined capital deployment. Regulators and lawmakers are taking a hard ...

Medline Inc. is guiding prospective investors to expect its IPO to price in the upper half of the marketed range, according ...

Lumexa Imaging hauled in $462.5 million during its initial public offering, far exceeding the $200 million the outpatient ...

Zenas's strong balance sheet, with $301.6M in cash and runway into late 2026, supports aggressive late-stage pipeline ...

QingSong Health Corporation wants to raise up to 601.9 million Hong Kong dollars, equivalent to US$77.3 million, by issuing 26.5 million shares at HK$22.68 each. Hanx Biopharmaceuticals wants to raise ...

The startup's new tech could compete with Big Tech's health AI projects from heavyweights like Alphabet and OpenAI.